As per this study the Global Molecular Diagnostics Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.
Molecular diagnostics describes a class of diagnostic tests that assess a person’s health specifically at a molecular level, detecting and measuring specific genetic sequences in DNA or RNA or the proteins they express. Molecular diagnostics identify the gene, RNA, and protein variations that specifies whether a specific person is predisposed to have a disease, whether they actually have a disease or whether a specific treatment option is likely to be effective for a specific disease. Molecular diagnostics tests can also detect and quantify the presence of specific viruses, bacteria, or types of cells.
The rising prevalence of infectious diseases such as tuberculosis, hepatitis and various types of cancer are the major factors boosting the market growth of molecular diagnostics. Moreover, rising government initiatives in order to standardize biopharmaceutical and health sector are also expected to expand the market growth over the forecast period. However, the high cost of diagnosis and lack of experienced professionals are some factors restraining market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of molecular diagnostics.
The broad molecular diagnostics market has been sub-grouped into technology, application, product, and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- In-Situ Hybridization
- Chips and Microarrays
- Mass Spectrometry
- DNA Sequencing
- Polymerase Chain Reaction (PCR)-Based Methods
- Other Technologies
- Infectious Disease
- Genetic Disease Screening
- Human Leukocyte Antigen Typing
- Blood Screening
By End User
- Other Products
- Other End Users
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for molecular diagnostics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Molecular Diagnostics Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the molecular diagnostics market include Abbott Laboratories, Agilent Technologies/Dako, Becton, Dickinson and Company, Cepheid Inc., Genomic Health Inc., Hologic Corporation, Illumina Inc., Myriad Genetics, Qiagen, Roche Diagnostics. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.